FABP6, hypermethylated SFRP1, XDH, PLAU, ADH1C, HSD17B2, and SPP1 have been identified more as a colorectal cancer biomarker than as a therapeutic target at present [113–119]. Here, FABP6 is linked to colorectal cancer.